Adela

About:

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Website: https://www.adelabio.com

Top Investors: OrbiMed, RA Capital Management, F-Prime Capital, Deerfield, LabCorp

Description:

Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adela’s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.

Total Funding Amount:

$108M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Foster City, California, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)adelabio.com

Founders:

Daniel Carvalho, Maneesh Jain, Scott Bratman

Number of Employees:

51-100

Last Funding Date:

2023-09-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai